本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

6.70
-0.3400-4.83%
盘后6.700.00000.00%18:44 EDT
成交量:5.46万
成交额:37.04万
市值:3,340.12万
市盈率:-0.45
高:7.00
开:6.93
低:6.64
收:7.04
数据加载中...
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report